Company Profile
MiMedx Stock Price, News & Analysis
- Ticker:
- MDXG
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.18 USD (+0.48%)
Close
Last updated: August 6, 2026
532M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, MDXG closed up 0.48% at $4.18. No new same-company headline was identified in the current news window.
Company overview
Placental Tissue Products
MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair.
Wound-Care Portfolio
The company has more than a decade of experience serving chronic and difficult-to-heal wounds. Products are used by clinicians across outpatient and other care settings where advanced wound coverage and healing support are required.
Surgical and Pipeline Products
The surgical portfolio includes AMNIOFIX, AMNIOEFFECT and particulate products. MIMEDX is also investing in newer products such as CHORIOFIX and in a randomized controlled study of EPIEFFECT.
Future catalysts
MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science. The company improves when the commercial base keeps compounding.
Recent news
- 01
- 02
MIMEDX to Acquire Sanara MedTech
Source: MiMedx
- 03
- 04
- 05
MIMEDX Announces Launch of G4Derm® Plus
Source: MiMedx
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MiMedx (MDXG)?
MiMedx (MDXG) most recently closed at 4.18 USD, a +0.48% move versus the previous session.
What is the market cap of MiMedx (MDXG)?
MiMedx currently has a market capitalization of 532M USD on BioPharmSignal.
What does MiMedx do?
Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience serving chronic and...
On which exchange is MDXG stock listed?
MiMedx (MDXG) is associated with NASDAQ, United States, Biopharma.
What is Placental?
MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science.
Which conditions is MiMedx targeting with Placental?
MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science.
How does MiMedx describe recent progress with Placental?
MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science.
What is Tissue?
Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery.